Show simple item record

dc.contributor.authorHajivalili, M
dc.contributor.authorPourgholi, F
dc.contributor.authorKafil, HS
dc.contributor.authorJadidi-Niaragh, F
dc.contributor.authorYousefi, M
dc.date.accessioned2018-08-26T05:42:14Z
dc.date.available2018-08-26T05:42:14Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/40602
dc.description.abstractAmyotrophic lateral sclerosis (ALS is a neurodegenerative disorder which is characterized by motor neuron (MN dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.
dc.language.isoEnglish
dc.relation.ispartofCurrent stem cell research & therapy
dc.subjectAmyotrophic Lateral Sclerosis
dc.subjectAnimals
dc.subjectHumans
dc.subjectMesenchymal Stem Cell Transplantation
dc.titleMesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.
dc.typearticle
dc.citation.volume11
dc.citation.issue1
dc.citation.spage41
dc.citation.epage50
dc.citation.indexPubmed


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record